Expected Moves

Pandox AB issues its Q3 2026 earnings, updating the market on hotel RevPAR metrics, lease income, and interest expense coverage off a $19.22 base.

Global central bank rate decisions in December will dictate real estate financing costs, driving Pandox's forward multiple from the $17.80 anchor.

Release of Q4 2026 results alongside statutory year-end property portfolio revaluations, moving the stock from $18.90.

Q1 2027 performance and forward guidance on peak summer hotel bookings, evaluated against a $17.50 entry point.

Market pricing of macroeconomic disruptions to corporate cross-border travel from a $18.70 base.